Overview

Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made.

This outstanding team from the M.D. Anderson Cancer Center takes an evidence-based approach to lung cancer management and explains ...

See more details below
Lung Cancer

Available on NOOK devices and apps  
  • NOOK Devices
  • NOOK HD/HD+ Tablet
  • NOOK
  • NOOK Color
  • NOOK Tablet
  • Tablet/Phone
  • NOOK for Windows 8 Tablet
  • NOOK for iOS
  • NOOK for Android
  • NOOK Kids for iPad
  • PC/Mac
  • NOOK for Windows 8
  • NOOK for PC
  • NOOK for Mac
  • NOOK Study
  • NOOK for Web

Want a NOOK? Explore Now

NOOK Book (eBook)
$128.49
BN.com price
(Save 42%)$224.95 List Price
Note: This NOOK Book can be purchased in bulk. Please email us for more information.

Overview

Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made.

This outstanding team from the M.D. Anderson Cancer Center takes an evidence-based approach to lung cancer management and explains these advances in depth. Comprehensive treatment guidelines are provided, the third edition of Lung Cancer explores vital issues such as:


  • Lung cancer susceptibility and risk assessment

  • The pathology and pathogenesis of peripheral lung adenocarcinoma including bronchioloalveolar carcinoma

  • Screening for early detection

  • Advances in molecular and genetic markers

  • The detection and treatment of pre-neoplastic lesions and screening for lung cancer

  • Novel therapies such as angiogenesis and multi-tyrosine kinase inhibitors


Lung Cancer is a concise summary of advances in lung cancer clinical research and treatment for the clinician and is an invaluable reference for respiratory physicians, medical oncologists, clinical and surgical oncologists.

The book contains predominantly black-and-white illustrations, with some color illustrations.

The second edition of this book is a concise and timely summary of recent advances and new research in the field of lung cancer emphasizing the biology, diagnosis, and treatment. It studies the factors influencing predisposition and the development of preneoplastic lesions, chemoprevention strategies, surgical methods, and current and future advances in radiation therapy. Editors consist of a surgeon, radiation oncologist and medical oncologist with contributions from an international list of 30 leading experts. New chapters to this edition include: Markers of Susceptibility, Three-Dimensional Conformal Radiotherapy, and Immunologic Approaches. New chapter covering thoracoscopy and its role in procedure and treatment. "...an excellent overview of a wide range of new developments in the clinical management and basic science of lung cancer. It should be essential reading for all practicing specialists in this field..." Review of the first edition from Thoracic Society News.

Read More Show Less

Editorial Reviews

Gregory A. Masters
This book attempts to describe the important basic science and clinical aspects of lung cancer. This is done in a standard format with chapters on the biology, evaluation, management, and detection of lung cancer by a number of accomplished authors in the field. This book was originally published five years ago. The editors' goal is to provide a succinct summary of the recent advances, both in basic research and clinical management, of the widening field of lung cancer. The scope and management of lung cancer has evolved dramatically in the last five years and an up-to-date version of this text is welcome. This book appropriately subdivides these important areas of research with attention given to preneoplastic lesions, as well as advances in the preoperative evaluation, surgical management, radiation techniques, and new developments in chemotherapeutic agents for this disease. A significant portion is devoted to new methods of detection of lung cancer including molecular techniques and immunologic and biologic approaches. The target audience includes clinicians, basic researchers, and clinical researchers in the field of lung cancer. It certainly will be appropriate for specialists in surgical oncology, medical oncology, radiation oncology, and possibly pulmonary medicine. The editors are highly accomplished clinicians and researchers in the field of lung cancer. The book is well organized. It includes basic science research and then progresses through chapters dealing with different management techniques including surgery, radiation, chemotherapy, and combined modality therapy. The text is well written, but there is a relative paucity of pictures, drawings, and graphics. Thevarious graphs and tables included, many of which are reproductions of prior work, are effective in presenting relevant data. The information is quite up-to-date, as much as is possible for a textbook, with references from within approximately 18 months available for each chapter. This book provides a clear but very brief table of contents and lacks any subheadings. It is presented in a relatively easy-to-read format with an attractive cover and large type. The appendix gives adequate references to various topics in standard fashion. This is an excellent review of the relevant basic science and clinical topics in lung cancer and would be an appropriate choice for any medical or scientific library and/or bookstore. It would also be a good reference in an oncology office and perhaps appropriate for some clinicians who deal specifically with lung cancer including surgeons, radiotherapists, or medical oncologists as well as basic science researchers in the field of lung cancer. I believe that the subject areas incorporate the important major topics in lung cancer with a possible exception of adequate description of screening, imaging, and pathology sections. These are not individually represented in the text.
Booknews
A broad reference updated from the 1993 edition to include new developments but also to reflect the shift of emphasis in studies of the biology to factors influencing predisposition and the development of pre-neoplastic lesions. The topics include familiar predisposition, lung-sparing operations, surgery for small-cell lung cancer, three- dimensional conformal radiotherapy in bronchogenic carcinoma, new chemotherapeutic agents, chemoprevention, photodynamic therapy and thoracic malignancies, and genetic manipulations for treating lung cancer. Annotation c. by Book News, Inc., Portland, Or.
Doody's Review Service
Reviewer: Gregory A. Masters, MD (Evanston Hospital)
Description: This book attempts to describe the important basic science and clinical aspects of lung cancer. This is done in a standard format with chapters on the biology, evaluation, management, and detection of lung cancer by a number of accomplished authors in the field. This book was originally published five years ago.
Purpose: The editors' goal is to provide a succinct summary of the recent advances, both in basic research and clinical management, of the widening field of lung cancer. The scope and management of lung cancer has evolved dramatically in the last five years and an up-to-date version of this text is welcome. This book appropriately subdivides these important areas of research with attention given to preneoplastic lesions, as well as advances in the preoperative evaluation, surgical management, radiation techniques, and new developments in chemotherapeutic agents for this disease. A significant portion is devoted to new methods of detection of lung cancer including molecular techniques and immunologic and biologic approaches.
Audience: The target audience includes clinicians, basic researchers, and clinical researchers in the field of lung cancer. It certainly will be appropriate for specialists in surgical oncology, medical oncology, radiation oncology, and possibly pulmonary medicine. The editors are highly accomplished clinicians and researchers in the field of lung cancer.
Features: The book is well organized. It includes basic science research and then progresses through chapters dealing with different management techniques including surgery, radiation, chemotherapy, and combined modality therapy. The text is well written, but there is a relative paucity of pictures, drawings, and graphics. The various graphs and tables included, many of which are reproductions of prior work, are effective in presenting relevant data. The information is quite up-to-date, as much as is possible for a textbook, with references from within approximately 18 months available for each chapter. This book provides a clear but very brief table of contents and lacks any subheadings. It is presented in a relatively easy-to-read format with an attractive cover and large type. The appendix gives adequate references to various topics in standard fashion.
Assessment: This is an excellent review of the relevant basic science and clinical topics in lung cancer and would be an appropriate choice for any medical or scientific library and/or bookstore. It would also be a good reference in an oncology office and perhaps appropriate for some clinicians who deal specifically with lung cancer including surgeons, radiotherapists, or medical oncologists as well as basic science researchers in the field of lung cancer. I believe that the subject areas incorporate the important major topics in lung cancer with a possible exception of adequate description of screening, imaging, and pathology sections. These are not individually represented in the text.
From the Publisher
“The current edition builds on the strength of the previous editions … .Overall, the book was well planned. Each chapter is a concise review of the recent literature, with detailed references. Where warranted, there are tables, black-and-white diagrams, and photographs that expand on the information provided in the text. This well-organized book will be useful to pulmonologists, thoracic surgeons, radiation oncologists, medical oncologists, and others with an interest in lung cancer.” (New England Journal of Medicine, December 2008)

“One of the most comprehensive and up-to-date treatises that I have surveyed … .I would recommend the book highly to anyone in allied disciplines.” (Doody's Book Reviews)


3 Stars from Doody
Read More Show Less

Product Details

  • ISBN-13: 9781444358667
  • Publisher: Wiley
  • Publication date: 8/26/2011
  • Sold by: Barnes & Noble
  • Format: eBook
  • Edition number: 3
  • Pages: 480
  • Sales rank: 1,088,383
  • File size: 7 MB

Meet the Author

Jack A. Roth, MD FACS, Professor and Chairman, Bud Johnson Clinical Distinguished Chair, The University of Texas M.D. Anderson Cancer Center, Department of Thoracic & Cardiovascular Surgery and Professor of Molecular and Cellular Oncology, Director, W.M. Keck Center for Cancer Gene Therapy, Houston, Texas, USA.

James D. Cox, MD, Professor and Head, Division of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

Waun Ki Hong, MD, American Cancer Society Clinical Research Professor, Charles A. LeMistre Distinguished Chair in Thoracic Oncology and Professor and Chairman, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

Read More Show Less

Read an Excerpt

Click to read or download

Read More Show Less

Table of Contents

Contributors.

Preface.

1 Smoking Cessation: Alexander V. Prokhorov (The University of Texas M.D. Anderson Cancer Center), Kentya H. Ford (The University of Texas M.D. Anderson Cancer Center) and Karen Suchanek Hudmon (Purdue University School of Pharmacy & Pharmaceutical Sciences).

2 Lung Cancer Susceptibility Genes: Joan E. Bailey-Wilson (National Human Genome Research Institute, Baltimore).

3 Lung Cancer Susceptibility and Risk Assessment Models: Xifeng Wu (The University of Texas M.D. Anderson Cancer Center), Hushan Yang, Jie Lin (National Cancer Center, Goyang), and Margaret R. Spitz (The University of Texas M.D. Anderson Cancer Center).

4 The Molecular Genetics of Lung Cancer: David S. Shames (The University of Texas Southwestern Medical Center), Mitsuo Sato (The University of Texas Southwestern Medical Center), and John D. Minna (The University of Texas Southwestern Medical Center).

5 Molecular Biology of Preneoplastic Lesions of the Lung: Ignacio I. Wistuba (The University of Texas M.D. Anderson Cancer Center) and Adi F. Gazdar (The University of Texas Southwestern Medical Center).

6 Detection of Preneoplastic Lesions: Stephen Lam (University of British Columbia).

7 Treatment of Preneoplastic Lesions of the Lung: Annette McWilliams (University of British Columbia).

8 The Pathology and Pathogenesis of Peripheral Lung Adenocarcinoma Including Bronchioloalveolar Carcinoma: Wilbur A. Franklin (University of Colorado Health Sciences Center).

9 Treatment of Bronchioloalveolar Carcinoma: Ji-Youn Han (National Cancer Center, Goyang), Dae Ho Lee (University of Ulsan and Asan Medical Center, Seoul), and Jin Soo Lee (National Cancer Center, Goyang).

10 Molecular Profiling for Early Detection and Prediction of Response in Lung Cancer: Jacob M. Kaufman (Vanderbilt University School of Medicine) and David P. Carbone (Vanderbilt-Ingram Cancer Center).

11 The Role for Mediastinoscopy in the Staging of Nonsmall Cell Lung Cancer: Carolyn E. Reed (Medical University of South Carolina).

12 Minimally Invasive Surgery for Lung Cancer: Michael Kent (Beth Israel Deaconess Medical Center,Boston), Miguel Alvelo-Rivera (University of Pittsburgh Medical Center), and James Luketich (University of Pittsburgh Medical Center).

13 Extended Resections for Lung Cancer: Philippe G. Dartevelle (Paris Sud University), Bedrettin Yildizeli (Marmara University Hospital, Istanbul), and Sacha Mussot (Hôpital Marie Lannelongue – Le Plessis Robinson).

14 Adjuvant Chemotherapy Following Surgery for Lung Cancer: Benjamin Besse (Institut Gustave Roussy, Villejuif) and Thierry Le Chevalier (Institut Gustave Roussy, Villejuif).

15 Induction Chemotherapy for Resectable Lung Cancer: Katherine M.W. Pisters (The University of Texas M.D. Anderson Cancer Center).

16 Image-Guided Radiation Therapy: Kenneth E. Rosenzweig (Memorial Sloan–Kettering Cancer Center) and Sonal Sura (Radiation Oncology Resident, New York City).

17 Stereotactic Body Radiation Therapy for Lung Cancer: Robert D. Timmerman (The University of Texas Southwestern Medical Center) and Brian D. Kavanagh (University of Colorado Comprehensive Cancer Center).

18 Proton Therapy: Joe Y. Chang (The University of Texas M. D. Anderson Cancer Center), Alfred R. Smith (The University of Texas M.D. Anderson Proton Therapy Center), and James D. Cox (The University of Texas M.D. Anderson Cancer Center).

19 Combinations of Radiation Therapy and Chemotherapy for Nonsmall Cell Lung Carcinoma: Zhongxing Liao (The University of Texas M.D. Anderson Cancer Center), Frank V. Fossella (The University of Texas M.D. Anderson Cancer Center), and Ritsuko Komaki (The University of Texas M.D. Anderson Cancer Center).

20 New Chemotherapeutic Agents in Lung Cancer: Anne S. Tsao (The University of Texas M.D. Anderson Cancer Center).

21 Immunologic Approaches to Lung Cancer Therapy: Jay M. Lee (David Geffen School of Medicine at UCLA), Steven M. Dubinett (David Geffen School of Medicine at UCLA), and Sherven Sharma (David Geffen School of Medicine at UCLA).

22 Epidermal Growth Factor Receptor Inhibitors: Lecia V. Sequist (Harvard Medical School) and Thomas J. Lynch (Massachusetts General Hospital).

23 Tumor Angiogenesis: Biology and Therapeutic Implications for Lung Cancer: Emer O. Hanrahan (The University of Texas M.D. Anderson Cancer Center), Monique Nilsson (The University of Texas M.D. Anderson Cancer Center), and John V. Heymach (The University of Texas M.D. Anderson Cancer Center).

24 Retinoids and Rexinoids in Lung Cancer Prevention and Treatment: Nishin Bhadkamkar (Emory University School of Medicine) and Fadlo R. Khuri (Emory University).

25 Proteasome Inhibition in Nonsmall Cell Lung Cancer Therapy: Minh Huynh (Kaiser Permanente Walnut Creek Medical Center) and Primo N. Lara Jr (University of California Davis Cancer Center, Sacramento).

26 Targeted Genetic Therapy for Lung Cancer: Jack Roth (The University of Texas M.D. Anderson Cancer Center).

27 Screening for Early Detection: James L. Mulshine (Rush University Medical Center).

28 Natural Agents for Chemoprevention of Lung Cancer: Amir Sharafkhaneh (Baylor College, Houston), Suryakanta Velamuri (Baylor College, Houston), Seyed Javad Moghaddam (The University of Texas M.D. Anderson Cancer Center),.

Vladimir Badmaev (Sabinsa Pharmaceutical, Inc., New Jersey), Burton Dickey (The University of Texas M.D. Anderson Cancer Center), and Jonathan Kurie (The University of Texas M.D. Anderson Cancer Center).

Index

Read More Show Less

Customer Reviews

Average Rating 1
( 1 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(1)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously
Sort by: Showing 1 Customer Reviews
  • Anonymous

    Posted May 17, 2014

    Camp

    Please chat and get to now each other. Instructions for raids will come once we have sufficient number of cats

    Was this review helpful? Yes  No   Report this review
Sort by: Showing 1 Customer Reviews

If you find inappropriate content, please report it to Barnes & Noble
Why is this product inappropriate?
Comments (optional)